PortfolioPortfolio mode

ABBV

AbbViestock

$258.151.81% today

Trade ABBV

← Research only mode

Research ABBV

ABBV · 90-day price history

Prediction models

All predictions →

Trend follower

Horizon: 1 week

Confidence1.00

Accuracy data accumulates as predictions are evaluated over time.

How this works

Compares a 10-day vs 50-day moving average. When the short-term average rises above the long-term average, the trend is up.

Not financial advice. Past accuracy does not guarantee future results.

Momentum

Horizon: 1 week

down

Confidence0.29

Accuracy data accumulates as predictions are evaluated over time.

How this works

Uses RSI (a gauge of recent buying/selling intensity) and 5-day rate-of-change to judge whether the stock has been pushed too far in one direction.

Not financial advice. Past accuracy does not guarantee future results.

Statistical trend

Horizon: 1 month

Confidence0.63

Accuracy data accumulates as predictions are evaluated over time.

How this works

Fits a trend line through the last 60 days of prices and measures how far the current price has strayed from it.

Not financial advice. Past accuracy does not guarantee future results.

Bull / Bear thesis

AI analysis

Bull case●

Stock is down, creating potential entry point for beginners

Price down 1.81% in session, offering opportunity to buy at lower prices

Price action

Major market indices contain this stock

ABBV is tracked in major indices showing established market position

Market positioning

Dividend-paying or stable business model

Large-cap company with established revenue streams

Company profile

Bear case●

Market-wide factors could pressure stock further

Macro environment and sector rotation are ongoing risks

Market dynamics

Valuation and entry timing matter

Even good companies can trade at unfavorable prices

Investment principles

Valuation and entry timing matter

Even good companies can trade at unfavorable prices

Investment principles

AI-generated from recent news and price action. Not financial advice. Educational only.

Recent news

AbbVie Submits EMA Application For SKYRIZI Subcutaneous Induction In Adults With Moderately To Severely Active Crohn's Disease, Backed By Phase 3 AFFIRM Data

Benzinga · Aug 26

This Benzinga report covers ABBV activity and market trends relevant to understanding stock movement.

If You Invested $100 In AbbVie Stock 10 Years Ago, You Would Have This Much Today

Benzinga · Aug 26

This Benzinga report covers ABBV activity and market trends relevant to understanding stock movement.

TG Therapeutics: Briumvi's Peak May Be Far Away (Rating Upgrade)

SeekingAlpha · Aug 26

This SeekingAlpha report covers ABBV activity and market trends relevant to understanding stock movement.

AbbVie Still Has Room To Run

SeekingAlpha · Aug 24

This SeekingAlpha report covers ABBV activity and market trends relevant to understanding stock movement.

Sanofi: Trump's Vaccine Policy Won't Break The Story

SeekingAlpha · Aug 24

This SeekingAlpha report covers ABBV activity and market trends relevant to understanding stock movement.

AI research companion

AI Research Companion

Loading…